Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Dacogen decitabine: Phase II data

Data from 93 patients in a Phase II trial showed that 20 mg/m 2

Read the full 143 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE